Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The evidence base is preclinical for IGF-1 LR3 specifically, with adjacent human data from native rhIGF-1 (mecasermin/Increlex)
The information provided is strictly for informational purposes only
Deficiencies can lead to serious health issues, affecting everything from energy levels to brain function
No dosing, administration, or treatment guidance is provided
AOD9604 does not meaningfully increase GH or IGF1 levels and is considered a modest, mechanistic fatsupport peptide rather than a cornerstone obesity treatment
We take time to learn about your health concerns, current symptoms, and treatment goals
US$ 23.55
US$ 23.19
US$ 21.83
US$ 24.01
US$ 28.04
US$ 28.20
